Blood:静脉血栓栓塞(VTE)和出血评估模型所忽视的预测因素

2020-02-26 不详 MedSci原创

中心点:通过系统方法,本研究确定了23个静脉血栓栓塞和15个出血的预后因素。这些因素在大多数广泛使用的风险评估模型中均没有被纳入考虑。摘要:可能存在许多住院患者静脉血栓栓塞(VTE)和出血的预测因素,但迄今为止,还没有系统研究和评估证据。Darzi等人开展了一项系统回顾,从开始到2018年5月,检索Medline和EMBASE,以明确住院患者VTE和出血的预后因素。审查员独立提取重复的数据,并使用

中心点:

通过系统方法,本研究确定了23个静脉血栓栓塞和15个出血的预后因素。

这些因素在大多数广泛使用的风险评估模型中均没有被纳入考虑。

摘要:

可能存在许多住院患者静脉血栓栓塞(VTE)和出血的预测因素,但迄今为止,还没有系统研究和评估证据。Darzi等人开展了一项系统回顾,从开始到2018年5月,检索Medline和EMBASE,以明确住院患者VTE和出血的预后因素。审查员独立提取重复的数据,并使用建议评估、发展和评估(GRADE)方法评估证据的可靠性。

在69410项引用中,最终纳入了17项研究,其中14个是关于VTE,共鉴定出29个候选预后因素;3个是关于出血,共鉴定了17个候选因素。

对于VTE,中等确定性证据显示可能与年龄、CRP升高、D-二聚体、纤维蛋白原水平、心率、血小板增多、白细胞增多、发热、腿部水肿、较低的Barthel指数评分、不动、瘫痪、静脉血栓栓塞病史、血栓、恶性肿瘤、危重疾病和感染有关。

对于出血,中度确定性证据显示可能与年龄、性别、贫血、肥胖、低血红蛋白、十二指肠溃疡、再住院、危重症、血小板减少、血恶液质、肝脏疾病、肾功能衰竭、抗血栓药物和中心静脉导管(CVC)有关。

大多数VTE风险评估模型(RAMs)都不包括CRP升高、Barthel指数降低、恶性肿瘤病史和心率升高。

本研究为VTE和出血住院患者管理中的风险预测、相关研究和VTE预防指南提供参考。

原始出处:


本文系梅斯医学(MedSci)原创编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1955471, encodeId=05b619554e121, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Tue Jan 05 13:44:00 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698044, encodeId=389b16980443e, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Aug 19 04:44:00 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264328, encodeId=78bf12643286a, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Fri Feb 28 05:44:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047772, encodeId=08a9104e772ff, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Feb 26 17:44:00 CST 2020, time=2020-02-26, status=1, ipAttribution=)]
    2021-01-05 xue8602
  2. [GetPortalCommentsPageByObjectIdResponse(id=1955471, encodeId=05b619554e121, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Tue Jan 05 13:44:00 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698044, encodeId=389b16980443e, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Aug 19 04:44:00 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264328, encodeId=78bf12643286a, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Fri Feb 28 05:44:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047772, encodeId=08a9104e772ff, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Feb 26 17:44:00 CST 2020, time=2020-02-26, status=1, ipAttribution=)]
    2020-08-19 fusion
  3. [GetPortalCommentsPageByObjectIdResponse(id=1955471, encodeId=05b619554e121, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Tue Jan 05 13:44:00 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698044, encodeId=389b16980443e, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Aug 19 04:44:00 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264328, encodeId=78bf12643286a, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Fri Feb 28 05:44:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047772, encodeId=08a9104e772ff, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Feb 26 17:44:00 CST 2020, time=2020-02-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1955471, encodeId=05b619554e121, content=<a href='/topic/show?id=0aeb991e44c' target=_blank style='color:#2F92EE;'>#静脉血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99174, encryptionId=0aeb991e44c, topicName=静脉血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Tue Jan 05 13:44:00 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1698044, encodeId=389b16980443e, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Wed Aug 19 04:44:00 CST 2020, time=2020-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1264328, encodeId=78bf12643286a, content=<a href='/topic/show?id=daf1100226fb' target=_blank style='color:#2F92EE;'>#预测因素#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100226, encryptionId=daf1100226fb, topicName=预测因素)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a57b78, createdName=朱睿睿, createdTime=Fri Feb 28 05:44:00 CST 2020, time=2020-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047772, encodeId=08a9104e772ff, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Feb 26 17:44:00 CST 2020, time=2020-02-26, status=1, ipAttribution=)]
    2020-02-26 CHANGE

    梅斯里提供了很多疾病的模型计算公式,赞一个!

    0

相关资讯

Blood:经外周静脉穿刺中心静脉置管明显增加儿童静脉血栓栓塞风险

中心点:经外周静脉穿刺中心静脉置管(PICCs)相比隧道式置管,会增加儿童的静脉血栓栓塞发生率。有血栓形成、白血病或多腔中心静脉导管史的儿童静脉血栓栓塞的风险增加。摘要:近年来,儿童静脉血栓栓塞(VTE)发生率急剧升高,大部分病例继发于中心静脉置管(CVCs)。对于CVCs,经外周静脉穿刺中心静脉置管(PICCs)的数量明显增多。Jaffray等人开展一多中心的、前瞻性观察性队列研究,招募6个月-

Lancet haemat:3期试验:利伐沙班治疗静脉血栓栓塞儿童的临床预后和安全性

儿童静脉血栓栓塞的治疗是基于从成人中获得的数据,几乎没有直接的文献证明其在儿童中的有效性和安全性。现研究人员对利伐沙班 vs 标准抗凝剂治疗静脉血栓栓塞儿童的疗效和安全性。本研究是一项多中心的、平行组、非盲的随机化研究,从28个国家的107家儿科医院招募已开始肝素治疗的急性静脉血栓栓塞的儿童(0-17岁),按2:1随机分至利伐沙班组或标准抗凝剂组。持续治疗3个月(2岁以下患儿1个月)。主要疗效预后

Hypertension:妊娠期高血压并发症与静脉血栓栓塞风险

总之,妊娠期高血压和先兆子痫与妊娠期和产后期以及之后的13年中VTE风险增加相关。

J Thromb Haemost:接受细胞周期依赖性激酶抑制剂治疗的乳腺癌患者静脉血栓栓塞风险

在临床实践中,mBC患者接受CDKI治疗的VTE率比试验中报道的要高2至5倍,并且可能与更差的结局相关。

Lancet haemat:全膝关节置换的患者预防静脉血栓栓塞的更佳措施

医院相关静脉血栓栓塞是一个主要的病人安全问题。为全膝关节置换的患者提供预防措施,已被认为是降低静脉血栓栓塞发生率的有效策略。现研究人员对在这种情况下所有可用的预防策略的相对有效性和安全性进行评估。研究人员对随机对照试验进行系统回顾和Meta分析,来评估静脉血栓栓塞预防治疗的相对效果和安全性,同时建立一个可评估这些方案的成本效益的经济模型,并更新NICE指南。Meta分析纳入25个随机对照试验。深静

J Thromb Haemost:阿哌沙班和达肝素在活动性恶性肿瘤相关的静脉血栓栓塞中的疗效

由此可见,接受VTE治疗的癌症患者口服阿哌沙班与较低的大出血和VTE复发率相关。